I can’t pull today’s live biotech news unless browsing is enabled. If you want real-time updates, I can fetch them and summarize. In the meantime, here are practical ways to stay updated and a ready-to-use daily digest format.
Where to check reliable biotech news (quick-start)
- Regulators and official sources: FDA press releases, EMA news, FDA approvals and safety notices, ClinicalTrials.gov updates.
- Major outlets: STAT News, Endpoints News, FierceBiotech, BioCentury, Nature News, Science Translational Medicine coverage.
- Company activity: press releases from biotech/pharma companies, and filings like SEC 8-Ks.
- Financial/markets: Reuters biotech desk, Bloomberg Health, Nasdaq press releases.
If you want a fast, daily digest you can copy into notes, use this template
- Top line: One sentence capturing the biggest development today (approval, trial result, major deal, or regulatory news).
- Regulatory/Approval: 1 item (drug/therapy, indication, agency, status).
- Clinical trials: 1–2 items (phase, disease area, key endpoints).
- Financing/Deals: 1 item (funding round, collaboration, acquisition).
- Technology/Platform: 1 item (new gene therapy approach, AI in discovery, platform milestone).
- Upcoming catalysts: next milestones or data readouts to watch.
- Quick take: any notable risk or caveat (e.g., trial design, sample size, safety signals).
What would you like right now?
- Want me to fetch today’s updates if you enable browsing?
- Or tell me your interests (oncology, neurology, gene therapy, rare diseases, or specific companies or tickers), and I’ll summarize the latest from those areas using reputable sources.